Edesa Biotech Inc — Rendiconto Finanziario (NASDAQ:EDSA) | MetaTrader

Apri il grafico completo

Notizie

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.95%

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.83%

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.76%

Le azioni di Edesa Biotech salgono sui dati positivi dello studio di Fase 3

Edesa Biotech stock surges on positive Phase 3 trial data

Edesa Biotech reports mortality reduction in phase 3 trial

Edesa Biotech aumenta il limite dell’offerta at-the-market a 2,26 milioni di dollari

Edesa Biotech increases at-the-market offering limit to $2.26 million

Edesa Biotech, Inc. (EDSA) Presents at LSX Investival Showcase Europe 2025 - Slideshow (NASDAQ:EDSA) 2025-11-17

Edesa Biotech riporta risultati positivi di Fase 3 per candidato farmaco contro ARDS

Edesa’s ARDS drug shows 25% reduction in death risk in phase 3 trial

Edesa Biotech reports positive Phase 3 results for ARDS drug candidate